{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:56:05Z","timestamp":1788580565376,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejpb.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:29:59Z","timestamp":1692757799000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS\/MS proteomics using a QconCAT technique"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-3210","authenticated-orcid":false,"given":"Jan","family":"Goelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-2847","authenticated-orcid":false,"given":"Gillian","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2247-1378","authenticated-orcid":false,"given":"Jonathan","family":"McGeehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8698-8352","authenticated-orcid":false,"given":"Christopher M.","family":"Titman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"J. W. Rattray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-0081","authenticated-orcid":false,"given":"Trevor N.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3996-9236","authenticated-orcid":false,"given":"Richard D.","family":"Horniblow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-9951","authenticated-orcid":false,"given":"Hannah K.","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.08.011_b0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejps.2018.07.022","article-title":"Gastric fluid composition in a paediatric population: Age-dependent changes relevant for gastrointestinal drug disposition","volume":"123","author":"Van Den Abeele","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.08.011_b0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2013.10.006","article-title":"Paediatric oral biopharmaceutics: key considerations and current challenges","volume":"73","author":"Batchelor","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bcp.12268","article-title":"Formulations for children: problems and solutions","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0020","first-page":"433","article-title":"Lactose-[13C]ureide breath test: a new, noninvasive technique to determine orocecal transit time in children","volume":"31","author":"Van Den Driessche","year":"2000","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/psp4.12764","article-title":"Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations","volume":"11","author":"Johnson","year":"2022","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt.142","article-title":"Failed Pediatric Drug Development Trials","volume":"98","author":"Momper","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2023.08.011_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-018-0677-y","article-title":"State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development","volume":"58","author":"Yellepeddi","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2023.08.011_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121670","article-title":"Practical and operational considerations related to paediatric oral drug formulation: An industry survey","volume":"618","author":"Van der Veken","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2023.08.011_b0045","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1038\/psp.2014.45","article-title":"Physiologically based pharmacokinetic modeling and simulation in pediatric drug development","volume":"3","author":"Maharaj","year":"2014","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425250802691074","article-title":"The Simcyp population-based ADME simulator","volume":"5","author":"Jamei","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejpb.2023.08.011_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107541","article-title":"Physiologically-based pharmacokinetic models for children: Starting to reach maturation?","author":"Verscheijden","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2023.08.011_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejps.2018.01.009","article-title":"Development and applications of a physiologically-based model of paediatric oral drug absorption","volume":"115","author":"Johnson","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2125.2011.03992.x","article-title":"Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?","volume":"72","author":"Cella","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2023.08.011_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105280","article-title":"Impact of gastrointestinal physiology on drug absorption in special populations\u2013\u2013An UNGAP review","volume":"147","author":"Stillhart","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpt.176","article-title":"Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group","volume":"98","author":"Brouwer","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ejpb.2023.08.011_b0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cpt.1112","article-title":"Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2023.08.011_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","article-title":"Emerging transporters of clinical importance: an update from the International Transporter Consortium","volume":"94","author":"Hillgren","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2023.08.011_b0100","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.121.000559","article-title":"Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics","author":"Kiss","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.119.089656","article-title":"Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine","volume":"48","author":"Couto","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.ejpb.2023.08.011_b0110","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.08.011_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122282","article-title":"The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patients","volume":"628","author":"de Waal","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2023.08.011_b0120","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"36","key":"10.1016\/j.ejpb.2023.08.011_b0125","doi-asserted-by":"crossref","first-page":"33275","DOI":"10.1074\/jbc.M204935200","article-title":"cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine*","volume":"277","author":"Madison","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2023.08.011_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1993.sp019540","article-title":"Annual review prize lecture. 'All hands to the sodium pump'","volume":"462","author":"Glynn","year":"1993","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.ejpb.2023.08.011_b0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","article-title":"Carboxylesterase in the liver and small intestine of experimental animals and human","volume":"81","author":"Taketani","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2023.08.011_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ddtec.2021.06.008","article-title":"Application of proteomics to understand maturation of drug metabolizing enzymes and transporters for the optimization of pediatric drug therapy","volume":"39","author":"Streekstra","year":"2021","journal-title":"Drug Discov. Today Technol."},{"issue":"5","key":"10.1016\/j.ejpb.2023.08.011_b0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2125.2001.01370.x","article-title":"Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis","volume":"51","author":"Johnson","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/acs.molpharmaceut.8b00941","article-title":"Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics","volume":"16","author":"Couto","year":"2019","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2023.08.011_b0155","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/cpt.1301","article-title":"Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens","volume":"105","author":"Drozdzik","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2023.08.011_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpba.2015.02.043","article-title":"Application of an LC-MS\/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique","volume":"110","author":"Harwood","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2023.08.011_b0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2013.07.031","article-title":"LC-MS\/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins","volume":"85","author":"Groer","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0170","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1208\/s12248-013-9521-3","article-title":"Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters","volume":"15","author":"Oswald","year":"2013","journal-title":"AAPS J."},{"issue":"6928","key":"10.1016\/j.ejpb.2023.08.011_b0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature01511","article-title":"Mass spectrometry-based proteomics","volume":"422","author":"Aebersold","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2023.08.011_b0180","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.113.055632","article-title":"Simultaneous Quantification of the Abundance of Several Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzymes in Human Liver Microsomes Using Multiplexed Targeted Proteomics","author":"Achour","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.ejpb.2023.08.011_b0185","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1021\/pr400279u","article-title":"Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters","volume":"12","author":"Russell","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejpb.2023.08.011_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107397","article-title":"Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice","volume":"203","author":"El-Khateeb","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2023.08.011_b0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpba.2014.08.016","article-title":"Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics","volume":"100","author":"Gr\u00f6er","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0200","doi-asserted-by":"crossref","first-page":"e00222","DOI":"10.1002\/prp2.222","article-title":"UGT concentrations in human rectal tissue after multidose, oral curcumin","volume":"4","author":"Asher","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1208\/s12248-014-9712-6","article-title":"Choice of LC-MS Methods for the Absolute Quantification of Drug-Metabolizing Enzymes and Transporters in Human Tissue: a Comparative Cost Analysis","volume":"17","author":"Al Feteisi","year":"2015","journal-title":"AAPS J."},{"issue":"8","key":"10.1016\/j.ejpb.2023.08.011_b0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nmeth774","article-title":"Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides","volume":"2","author":"Beynon","year":"2005","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejpb.2023.08.011_b0215","article-title":"Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics","author":"Al-Majdoub","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jphp.12955","article-title":"Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products \u2013 a PEARRL review","volume":"71","author":"Guimar\u00e3es","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.08.011_b0225","unstructured":"Use, C.f.M.P.f.H., Reflection paper: formulations of choice for the paediatric population. EMEA, London, 2006."},{"issue":"6","key":"10.1016\/j.ejpb.2023.08.011_b0230","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria","volume":"25","author":"Kamiie","year":"2008","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0235","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2125.2005.02343.x","article-title":"Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein","volume":"59","author":"Pinto","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2023.08.011_b0240","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects","volume":"13","author":"Miyauchi","year":"2016","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-409X(97)00041-0","article-title":"The barrier function of CYP3A4 and P-glycoprotein in the small bowel","volume":"27","author":"Watkins","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.26.3.227","article-title":"Comparison of weight, depth, and diagnostic adequacy of specimens obtained with 16 different biopsy forceps designed for upper gastrointestinal endoscopy","volume":"26","author":"Danesh","year":"1985","journal-title":"Gut"},{"issue":"23","key":"10.1016\/j.ejpb.2023.08.011_b0255","doi-asserted-by":"crossref","first-page":"12791","DOI":"10.3390\/ijms222312791","article-title":"Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics","volume":"22","author":"Grangeon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0260","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2023.08.011_b0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.molpharmaceut.7b00772","article-title":"High Expression of UGT1A1\/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human","volume":"15","author":"Akazawa","year":"2018","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2023.08.011_b0270","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2023.08.011_b0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tox.2015.02.007","article-title":"Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation","volume":"330","author":"Chen","year":"2015","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.ejpb.2023.08.011_b0280","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/dmd.115.068957","article-title":"Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny","volume":"44","author":"Hines","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0285","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.ejpb.2023.08.011_b0290","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00003088-199631060-00003","article-title":"Clinical pharmacokinetics of sedatives in neonates","volume":"31","author":"Jacqz-Aigrain","year":"1996","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ejpb.2023.08.011_b0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003088-199835010-00003","article-title":"Clinical pharmacology of midazolam in infants and children","volume":"35","author":"Blumer","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ejpb.2023.08.011_b0300","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40262-013-0050-0","article-title":"A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults","volume":"52","author":"Ince","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00228-009-0741-5","article-title":"Ontogeny of midazolam glucuronidation in preterm infants","volume":"66","author":"de Wildt","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2023.08.011_b0310","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00007691-200502000-00018","article-title":"Pharmacodynamics of midazolam in pediatric intensive care patients","volume":"27","author":"de Wildt","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"7","key":"10.1016\/j.ejpb.2023.08.011_b0315","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1097\/01.ccm.0000084806.15352.da","article-title":"Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients","volume":"31","author":"de Wildt","year":"2003","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0320","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2125.2002.01223.x","article-title":"Pharmacokinetics and metabolism of oral midazolam in preterm infants","volume":"53","author":"de Wildt","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2023.08.011_b0325","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0009-9236(01)15882-0","article-title":"Pharmacokinetics and metabolism of intravenous midazolam in preterm infants","volume":"70","author":"de Wildt","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00679782","article-title":"The pharmacokinetics of midazolam in paediatric patients","volume":"37","author":"Payne","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejpb.2023.08.011_b0335","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","article-title":"Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers","volume":"53","author":"Brill","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ejpb.2023.08.011_b0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/psp4.12295","article-title":"First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates","volume":"7","author":"Brussee","year":"2018","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0345","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpt.1537","article-title":"Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper","volume":"106","author":"Prasad","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejpb.2023.08.011_b0350","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cpt.819","article-title":"Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS\/MS Proteomics","volume":"103","author":"Bhatt","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ejpb.2023.08.011_b0355","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1021\/acs.molpharmaceut.7b00364","article-title":"Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes","volume":"14","author":"Wegler","year":"2017","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2023.08.011_b0360","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/ac048455k","article-title":"Quantitative proteomic analysis by accurate mass retention time pairs","volume":"77","author":"Silva","year":"2005","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.ejpb.2023.08.011_b0365","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/dmd.119.089656err","article-title":"Correction to \u201cQuantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine\u201d","volume":"48","author":"Couto","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0370","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bcp.2011.10.017","article-title":"Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum","volume":"83","author":"Tucker","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2023.08.011_b0375","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/dmd.114.056929","article-title":"Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters","volume":"42","author":"Mooij","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.ejpb.2023.08.011_b0380","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10735-011-9363-1","article-title":"Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos","volume":"42","author":"Konieczna","year":"2011","journal-title":"J. Mol. Histol."},{"issue":"6","key":"10.1016\/j.ejpb.2023.08.011_b0385","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2133\/dmpk.24.529","article-title":"mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues","volume":"24","author":"Fakhoury","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.ejpb.2023.08.011_b0390","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1124\/dmd.105.005611","article-title":"LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE","volume":"33","author":"Fakhoury","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2023.08.011_b0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2004.12.005","article-title":"Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues","volume":"231","author":"Miki","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.ejpb.2023.08.011_b0400","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/dmd.111.041731","article-title":"Oral availability of cefadroxil depends on ABCC3 and ABCC4","volume":"40","author":"de Waart","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0405","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdd.2062","article-title":"Quantifying gut wall metabolism: methodology matters","volume":"38","author":"Hatley","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"issue":"5","key":"10.1016\/j.ejpb.2023.08.011_b0410","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/dmd.113.056291","article-title":"Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry","volume":"42","author":"Sato","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.ejpb.2023.08.011_b0415","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ac201704a","article-title":"Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry","volume":"84","author":"Harbourt","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2023.08.011_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127413","article-title":"Comparative study of concatemer efficiency as an isotope-labelled internal standard for allergen quantification","volume":"332","author":"Gavage","year":"2020","journal-title":"Food Chem."},{"issue":"21","key":"10.1016\/j.ejpb.2023.08.011_b0425","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1021\/ac402326v","article-title":"Quantification of Transferrin in Human Serum Using Both QconCAT and Synthetic Internal Standards","volume":"85","author":"Zimmerman","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2023.08.011_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2022.104572","article-title":"A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins","volume":"261","author":"Vasilogianni","year":"2022","journal-title":"J. Proteomics"},{"issue":"2","key":"10.1016\/j.ejpb.2023.08.011_b0435","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0016-5085(88)90421-0","article-title":"Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms","volume":"94","author":"West","year":"1988","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ejpb.2023.08.011_b0440","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.120.090738","article-title":"Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine","volume":"48","author":"Zhang","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"23","key":"10.1016\/j.ejpb.2023.08.011_b0445","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/pmic.201600283","article-title":"Generation of accurate peptide retention data for targeted and data independent quantitative LC-MS analysis: Chromatographic lessons in proteomics","volume":"16","author":"Krokhin","year":"2016","journal-title":"Proteomics"},{"issue":"8","key":"10.1016\/j.ejpb.2023.08.011_b0450","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/acs.analchem.8b00525","article-title":"Conventional-Flow Liquid Chromatography-Mass Spectrometry for Exploratory Bottom-Up Proteomic Analyses","volume":"90","author":"Lenco","year":"2018","journal-title":"Anal. Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112300214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112300214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:52:15Z","timestamp":1760547135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112300214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":90,"alternative-id":["S093964112300214X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.08.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS\/MS proteomics using a QconCAT technique","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}